19 results
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
10 May 18
Bio-Path Holdings Appoints Dr. Anas Younes to Scientific Advisory Board
5:02pm
of Medicine. He completed his internal medicine residency training at SUNY Downstate Medical Center and his pathology residency at the Medical College of Ohio … . He completed his hematology fellowship training at MSK.
About Bio-Path Holdings, Inc.
Bio-Path is a biotechnology company developing DNAbilize®
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
26 Mar 14
Bio-Path Holdings, Inc. Appoints Ulrich W. Mueller Chief Operating Officer
12:00am
-University of Washington comprehensive cancer consortium including compliance, clinical staff training, regulatory affairs, protocol development
424B3
j61t9jbf17vzlr9
30 Mar 12
Prospectus supplement
12:00am
424B3
f4nuz8vqaq3qeoq6c146
1 Apr 11
Prospectus supplement
12:00am
424B3
jtw5we60qmk7
29 Jul 10
Prospectus supplement
12:00am
S-1
iqy hkssmmnw79rwcqc
17 Jun 10
IPO registration
12:00am
DEF 14A
mh2jv
29 May 09
Definitive proxy
12:00am
10-K
5m9758 1p5uhmp4ak
3 Apr 09
Annual report
12:00am
8-K
s5e2y2txh21 j8
19 Feb 08
Completion of Acquisition or Disposition of Assets
12:00am
SB-2
1muk92seyg vxw4gv
8 May 03
Registration of securities for small business issuer
12:00am
SB-2
EX-1
ynbkewb97lrj7 4el
8 May 03
Registration of securities for small business issuer
12:00am
- Prev
- 1
- Next